PATIENTS' CONCEPTIONS OF THERAPISTS.

F. Tyler,W. Simmons

DOI: https://doi.org/10.1002/1097-4679(196401)20:1<122::AID-JCLP2270200121>3.0.CO;2-1

Journal of Clinical Psychology

Abstract:

What problem does this paper attempt to address?

Plant protoplasts: status and biotechnological perspectives.

Michael R. Davey,P. Anthony,J. Power,Kenneth C. Lowe

DOI: https://doi.org/10.1016/J.BIOTECHADV.2004.09.008

IF: 17.681

2005-03-01

Biotechnology Advances

Abstract:
MON-107 Diabetic Ketoacidosis at Type 1 Diabetes Diagnosis in Children from a Large Centre (hangzhou, China)

Wei Peng,Binghan Jin,Jinna Yuan,Guanping Dong,Hu Lin,Ke Huang,Wei Wu,José G B Derraik,Junfen Fu

DOI: https://doi.org/10.1210/jendso/bvaa046.1645

2020-01-01

Journal of the Endocrine Society

Abstract:Abstract Objective: To review the clinical symptoms and biochemical parameters associated with diabetic ketoacidosis (DKA) in children newly diagnosed with type 1 diabetes (T1D) in our single medical centre over 10 years. Methods: Participants were children aged <16 years diagnosed with T1D between 1 January 2009 and 31 December 2018 at the Children’s Hospital, at Zhejiang University School of Medicine (Hangzhou, China). DKA occurrence was assessed by blood gases using pH and bicarbonate. The severity of DKA was categorized according to ISPAD 2014 guidelines, as mild, moderate, or severe. The child’s history prior to diagnosis was recorded, and patients underwent a number of clinical assessments, including anthropometry, biochemical parameters, and OGTT. The demographic and clinical characteristics of children with and without DKA were compared. Results: 681 patients (314 boys and 367 girls) were diagnosed with T1D over the study period. 341 (50.1%) had DKA at diagnosis, with yearly rates ranging from 45.0% to 56.8%. Eight cases had missing data on severity, but 120 had mild (36.0%), 100 moderate (30.0%), and 113 severe (33.9%) DKA. Children with DKA were younger than those without DKA (7.2 vs 8.2 years, respectively; p=0.001), and were more likely to report vomiting (13.2% vs 1.5%; p<0.001), loss of appetite (3.2% vs 0.9%; p=0.031), fatigue (39.3% vs 5.6%; p<0.001), and abdominal pain (9.1% vs 1.5%; p<0.001) prior to T1D diagnosis. The classical symptoms of diabetes were similar in children with and without DKA, such as polyuria (86.8% vs 90.3%, respectively; p=0.153), polydipsia (90.6% vs 91.5%; p=0.696), polyphagia (26.4% vs 30.3%; p=0.259), and weight loss (50.7% vs 50.6%; p=0.970). Children with DKA had higher blood lipids and fasting insulin levels at presentation, but displayed similar HbA1c levels. Conclusions: We report a high incidence of DKA at our centre (50%) among children diagnosed with T1D. As most children displayed classical symptoms of diabetes, it is important to increase community awareness of the disease to ensure an early diagnosis and lower the risk of children presenting with DKA.
Changes of blood electrolytes and lipids in type 1 diabetes mellitus children with ketoacidosis (DKA)

Niumin Wang,Xiaoyun Zhou,Li Liang,Guanping Dong,Lizhong Du

2006-01-01

Abstract:Objective: To analyze blood electrolyte and serum lipid profiles, and to study the relationship between hypokalemia and the effect of insulin treatment in type 1 diabetes mellitus children with ketoacidosis. Methods: The clinical characteristics and laboratory indexes of the 101 type 1 diabetes mellitus children were collected, who were firstly diagnosed in our hospital from 1999 to 2004. The blood electrolyte and serum lipids recorded at diagnosis were retrospectively analyzed. The effect of was studied. Results: Mild, moderate and severe ketoacidosis were in 16 children (15.8%), 9 Chidren (8.9%), 17 children (16.8%), respectively. The blood glucose, anion gap, TG, and TC were higher in DKA group than those in non-DKA group. Eleven patients had pseudohyponatremia. The occurrence rate of hypokalemia in DKA group and non-DKA group was 22/42 (52.4%) and 20/59 (33.9%), respectively. The duration of hospitalization and duration of hypokalemia recovery in DKA group and non-DKA group was (13.64 ± 4.77) d, (140.0 ± 10.6) h and (10.75 ± 4.92) d, (96.0 ± 11.8) h, respectively. There were differences between the two groups. The time of blood glucose getting normal was 3.6 - 8.4 h in DKA with hypokalemia group, 5.8 - 12.2 h in DKA without hypokalemia group. There were differences between the two groups (t = 5.623, P < 0.01). The time of ketosis and urine Ketone becoming negative in DKA without hypokalemia group was shorter than that in DKA with hypokalemia group. There were significant differences between the two groups (t = 5.623 P < 0.01; t = 6.167, P < 0.01). Conclusions: Parents should know the importance of pseudohyponatremia in children. Elevation of blood glucose may increase the incidence rate of hypokalemia. Insulin should be reduced in the amount in type 1 diabetes mellitus children with DKA.
A 10-Year Review of Childhood Type 1 Diabetes Mellitus and the Clinical Value of Interleukin-10 in Diabetic Ketoacidosis

Yang-Li Dai,Jun-Fen Fu,Li Liang,Guan-Ping Dong

2010-01-01

Abstract:OBJECTIVE:To review the incident status of childhood type 1 diabetes mellitus hospitalized in the Children's Hospital of Zhejiang University School of Medicine from 1999 to 2009 and to explore the clinical value of IL-10 in diabetic ketoacidosis.METHODS:The clinical data of 263 children with type 1 diabetes mellitus hospitalized in the Children's Hospital of Zhejiang University School of Medicine from January 1999 to February 2009 were retrospectively reviewed. Serum lipid levels were measured in 48 children with type 1 diabetes mellitus and in 24 healthy children. The diabetic children were classified into two subgroups, with or without ketoacidosis. Serum lipid and cytokines levels were compared.RESULTS:Childhood type 1 diabetes mellitus was common in females (56.3%). The peak incident age of the disease was between 6 and 11.9 years. Diabetic ketoacidosis was as the presenting symptom for the first visit in 86 cases (32.7%). The levels of serum lipid, blood glucose and HbA1c in diabetic children with ketoacidosis were significantly higher than those without ketoacidosis (P<0.05). Logistic analysis demonstrated that the increased levels of blood glucose, serum lipid and HbA1c were risk factors for diabetic ketoacidosis. The level of serum IL-10 in diabetic children with ketoacidosis was significantly higher than that in patients without ketoacidosis (P<0.01), while there were no differences in serum levels IL-2, IL4, IL-6, TNF-α and IFN-γ between them. Serum levels IL-2, IL-4, IL-6, IL-10, TNF-α and IFN-γ in diabetic children were significantly higher than those in healthy children (P<0.01).CONCLUSIONS:Ketoacidosis is a common acute complication of type 1 diabetes mellitus. The disorders of glucose and lipid metabolism are the risk factors for ketoacidosis in diabetic children. IL-10 may be a sensitive index of diabetic ketoacidosis in children with type 1 diabetes mellitus.
Changes of blood electrolytes and lipids in type 1 diabetes meilitus children with ketoacidosis(DKA)

ZHOU Xiaoyun,LIANG Li,DONG Guanping,DU Lizhong

DOI: https://doi.org/10.3760/j.issn:1671-0282.2006.07.014

2006-01-01

Abstract:Objective To analyze blood electrolyte and serum lipid profiles,and to study the relationship between hypokalemia and the effect of insulin treatment in type 1 diabetes mellitus children with ketoacidosis.Methods The clinical characteristics and laboratory indexes of the 101 type 1 diabetes mellitus children were collected,who were firstly diagnosed in our hospital from 1999 to 2004.The blood electrolyte and serum lipids recorded at diagnosis were retrospectively analyzed.The effect ofwas studied.Results Mild,moderate and severe ketoacidosis were in 16 children(15.8%), 9Chidren(8.9%),17 children(16.8%),respectively.The blood glucose,anion gap,TG,and TC were higher in DKA group than those in non-DKA group.Eleven patients had pseudohyponatremia.The occurrence rate of hypokalemia in DKA group and non-DKA group was 22/42(52.4%) and 20/59(33.9%),respectively.The duration of hospitalization and duration of hypokalemia recovery in DKA group and non-DKA group was(13.64±4.77)d,(140.0±10.6)h and (10.75±4.92)d,(96.0±11.8)h,respectively.There were differences between the two groups.The time of blood glucose getting normal was 3.6～8.4 h in DKA with hypokalemia group,5.8～12.2 h in DKA without hypokalemia group.There were differences between the two groups(t=5.623,P＜0.01).The time of ketosis and urine Ketone becoming negative in DKA without hypokalemia group was shorter than that in DKA with hypokalemia group.There were significant differences between the two groups(t=5.623 P＜0.01;t=6.167,P＜0.01).Conclusions Parents should know the importance of pseudohyponatremia in children.Elevation of blood glucose may increase the incidence rate of hypokalemia.Insulin should be reduced in the amount in type 1 diabetes mellitus children with DKA.
Influence of a lymphokine fraction containing eosinophil stimulation promoter (ESP) on oxidative and degranulation responses of murine eosinophils.

T. H. Rand,D. Colley

DOI: https://doi.org/10.1016/0008-8749(82)90267-2

IF: 4.178

1982-08-01

Cellular Immunology

Abstract:
Platelet-to-Lymphocyte Ratio: A Novel Prognostic Factor for Prediction of 90-day Outcomes in Critically Ill Patients With Diabetic Ketoacidosis.

Wen-Yue Liu,Shi-Gang Lin,Li-Ren Wang,Chen-Chen Fang,Yi-Qian Lin,Martin Braddock,Gui-Qi Zhu,Zhongheng Zhang,Ming-Hua Zheng,Fei-Xia Shen

DOI: https://doi.org/10.1097/MD.0000000000002596

IF: 1.6

2016-01-01

Medicine

Abstract:Diabetic ketoacidosis (DKA) is a life-threatening acute complication of diabetes mellitus and the novel systemic inflammation marker platelet-to-lymphocyte ratio (PLR) may be associated with clinical outcome in patients with DKA. This study aimed to investigate the utility of PLR in predicting 90-day clinical outcomes in patients with DKA. Patient data exacted from the Multiparameter Intelligent Monitoring in Intensive Care II (MIMIC II) database was analyzed. A cutoff value for PLR of 267.67 was determined using Youden index (P < 0.05) and used to categorize subjects into a high PLR group and a low PLR group. The hazard ratios (HRs) and 95% confidence intervals (CIs) for DKA were calculated across PLR. Clinical outcomes in our study were defined as intensive care unit (ICU) 90-day readmission and all-cause mortality. A total of 278 ICU admissions were enrolled and stratified by cutoff value of PLR. The incidence of readmission and mortality was 17.8% in the high PLR group, significantly higher than 7.4% in the low PLR group. In the multivariable model, after adjusting for known confounding variables including clinical parameters, comorbidities, laboratory parameters, the HRs for DKA were 2.573 (95% CI 1.239-5.345; P = 0.011), 2.648 (95% CI 1.269-5.527; P = 0.009), and 2.650 (95% CI 1.114-6.306; P = 0.028), respectively. The Kaplan-Meier survival curve showed that a high PLR level was associated with a higher risk for 90-day outcomes in patients with DKA. The authors report that higher PLR presents a higher risk for 90-day incidence of readmission and mortality in patients with DKA. It appears to be a novel independent predictor of 90-day outcomes in critically ill DKA patients in ICU units.
1956-LB: Altered Gut Microbiota and Short-Chain Fatty Acids in Children with Diabetic Ketoacidosis at Onset of Type 1 Diabetes

YAN NI,YARU LIU,HU LIN,GUANPING DONG,JUNFEN FU

DOI: https://doi.org/10.2337/db24-1956-lb

IF: 7.7

2024-01-01

Diabetes

Abstract:Objective: Diabetic ketoacidosis (DKA) stands as the most common acute hyperglycaemic complication with relatively high mortality rate among children diagnosed with type 1 diabetes (T1D). Previous studies have shed light on gut dysbiosis in newly-onset T1D children, but research specifically targeting the gut microbiota and microbial metabolites in patients with DKA remains scarce. Methods: Shotgun metagenomic analysis was conducted on fecal samples of 90 healthy children (HC) and 96 newly diagnosed T1D children, including 32 patients who presented with DKA upon admission. Additionally, short-chain fatty acids (SCFAs) were quantified using GC/MS. Results: Gut microbiome indicated evident differences between T1D and healthy controls. At baseline, the phylum Bacteroidetes exhibited predominance in the DKA subgroup, while Firmicutes prevailed in the children without DKA. Compositional analysis unveiled increased levels of enteroviruses in the DKA group, encompassing Staphylococcus aureus and Streptococcus viridans, among others. Concurrently, various SCFA-producing microbiota (Anaerobutyricum, Dialister, Ruminococcus, Roseburia, Dorea, and Butyricicoccus) were significantly reduced in the DKA group. Correspondingly, targeted metabolomics analysis further corroborated significant reductions in the concentrations of SCFAs in children with DKA. Subsequent Spearman correlation analysis revealed the significant correlations between clinical parameters indicative of disease severity (bicarbonate, pH, urinary ketone, HbA1c), SCFAs, and SCFA-producing microbiota. Conclusions: We reported a reduction of SCFAs and SCFA-producing bacteria in the fecal samples of T1D children experiencing DKA at onset. Our findings suggest a potential therapeutic avenue involving the modulation of gut microbiota and associated SCFA metabolism in the pathogenesis of T1D and onset DKA. Y. Ni: None. H. Lin: None. G. Dong: None. J. Fu: None. This study is funded by the National Key Research and Development Program of China (2021YFC2701901 and 2021YFC2701904) and Zhejiang Provincial Key Science and Technology Project (LGF21H070004).
Acquired atopic disease after liver transplantation in children; similarities to and differences from adults: a preliminary study

E. Topal,F. Çatal,M. Selimoğlu,H. Karabıber,T. Kılıç,A. Baskiran,E. Şenbaba,S. Yılmaz

DOI: https://doi.org/10.1097/MEG.0000000000000142

2014-09-01

Abstract:Objective The aim of this study was to determine the similarities and differences in the frequency and follow-ups of newly diagnosed atopic diseases after liver transplantation in pediatric and adult patients. Materials and methods Patients who underwent liver transplants between 2005 and 2013 and who are still alive were enrolled in the study. Patients who came for checkups filled out a survey evaluating atopic diseases. Those who had an atopic disease before transplantation were excluded from the study. Results A total of 165 patients were enrolled in this study; 114 (69.1%) were males and 29 (17.6%) were children. The average transplantation age was 40.8 (0.3–67) years, and the most frequent reason for transplantation was chronic viral hepatitis. In 22 patients, atopic diseases [allergic rhinitis in nine patients (5.5%), asthma in six patients (3.9%), atopic eczema in six patients (3.9%), food allergy in six patients (3.9%), and drug allergy in one patient (0.6%)] developed after transplantation. Atopic diseases after transplantation were more common in children (P=0.03). When the atopic diseases were examined on a case-by-case basis, there were no differences between children and adults with respect to asthma (P=0.284), allergic rhinitis (P=1.0), or atopic eczema (P=0.284), but food allergy (P=0.009) and peripheral eosinophilia (P=0.002) were more common in children. The periodicity of allergic diseases after transplantation (P=0.192) and total IgE levels (P=0.086) were similar. Conclusion Atopic diseases developed after liver transplantation and had a greater impact on children than adults. Therefore, after undergoing liver transplantation, patients should be monitored closely for signs of atopic diseases.
A HOSPITAL BASED PROSPECTIVE STUDY TO ASSESSED THE CORRELATION BETWEEN GLYCEMIC CONTROL, LIPID PROFILE AND ORAL LEUKOPLAKIA IN DIABETES PATIENTS

Kiran Tak,Umesh Chahar,Sapna Singh Choudhary

Abstract:Background: Diabetes mellitus is rapidly becoming a common metabolic problem in urban and rural populations. The relationship between HbA1c and leukoplakia may be important with respect to diabetes. Even though there is a strong association between diabetes and leukoplakia, a causal mechanism for that has not been elucidated. The aim of this study to assessed the correlation between glycemic control, lipid profile and oral leukoplakia in diabetes patients. Materials and Methods: This is a case control study done on 207 cases of diabetes mellitus attending OPD/ IPD and Diabetic Care and Research Center, Department of Medicine, S.P. Medical College, Bikaner were taken as per WHO criteria. 190 cases without diabetes mellitus matched for confounding factors were taken as controls. Diagnostic criteria for abnormalities of the oral mucosa were in accordance with World Health Organization (WHO) guidelines. Confirmation of the diagnosis was done on histopathological examination by incisional biopsy. Results: Our study showed that mean age in study group was 53.64 17.07 years while in control group it was 43.07 18.25 years, and this difference was found statistically highly significant (p<0.001). On applying student ‘t’ test the difference was found statistically highly significant (p<0.001) in education status in both groups. Out of total 207 study group 100 cases had their HbA1c level >9.0 while in control group no case had HbA1c >9.0. Mean HbA1c in study group was 8.93 1.54% while in control group it was 5.08 0.6%, and this difference was found statistically highly significant (p<0.001). Leukoplakia was present in 9(4.4%) cases of study group and 3(1.6%) cases of control group. The present study showed multiple linear regression analysis of different parameters in relation to leukoplakia in study and control groups. Increasing trend was shows at all the time when we add BMI, WHR, TG, TC, HDL, LDL, RBS and HbA1c. Conclusion: We concluded that occurrence of leukoplakia was higher in diabetics patients compared to normoglycemic healthy individuals. These findings necessitated regular clinical examinations to ensure early diagnosis and prompt management of leukoplakia in diabetes and dyslipidemic patients.

Medicine
Clinical and biochemical profile of 786 sequential episodes of diabetic ketoacidosis in adults with type 1 and type 2 diabetes mellitus

Emma Ooi,Katrina Nash,Lakshmi Rengarajan,Eka Melson,Lucretia Thomas,Agnes Johnson,Dengyi Zhou,Lucy Wallett,Sandip Ghosh,Parth Narendran,Punith Kempegowda

DOI: https://doi.org/10.1136/bmjdrc-2021-002451

2021-12-01

Abstract:Introduction We explored the clinical and biochemical differences in demographics, presentation and management of diabetic ketoacidosis (DKA) in adults with type 1 and type 2 diabetes. Research design and methods This observational study included all episodes of DKA from April 2014 to September 2020 in a UK tertiary care hospital. Data were collected on diabetes type, demographics, biochemical and clinical features at presentation, and DKA management. Results From 786 consecutive DKA, 583 (75.9%) type 1 diabetes and 185 (24.1%) type 2 diabetes episodes were included in the final analysis. Those with type 2 diabetes were older and had more ethnic minority representation than those with type 1 diabetes. Intercurrent illness (39.8%) and suboptimal compliance (26.8%) were the two most common precipitating causes of DKA in both cohorts. Severity of DKA as assessed by pH, glucose and lactate at presentation was similar in both groups. Total insulin requirements and total DKA duration were the same (type 1 diabetes 13.9 units (9.1–21.9); type 2 diabetes 13.9 units (7.7–21.1); p=0.4638). However, people with type 2 diabetes had significantly longer hospital stay (type 1 diabetes: 3.0 days (1.7–6.1); type 2 diabetes: 11.0 days (5.0–23.1); p<0.0001). Conclusions In this population, a quarter of DKA episodes occurred in people with type 2 diabetes. DKA in type 2 diabetes presents at an older age and with greater representation from ethnic minorities. However, severity of presentation and DKA duration are similar in both type 1 and type 2 diabetes, suggesting that the same clinical management protocol is equally effective. People with type 2 diabetes have longer hospital admission.

endocrinology & metabolism
Monocytic Human Leukocyte Antigen-DR Expression Levels to Predict Outcome in Children With Severe Sepsis

Nanmaaran Periyannan Thangavel,Narayanan Parameswaran,Prabhu Manivannan,Jaikumar Govindaswamy Ramamoorthy

2024-07-23

Abstract:Objective: To assess the association between monocytic Human Leukocyte Antigen-DR (mHLA-DR)expression and outcome in children with severe sepsis. Methods: Consecutive children, aged 29 days to 15 years, who were admitted with severe sepsis or septic shock in the pediatric intensive care unit (PICU) were enrolled. mHLA-DR expression (antigen bound per cell (ABC)) was assessed on two time points: between 72 to 120 hours (P1) and 121 to 168 hours (P2), of stay in PICU and the difference between the two was calculated as delta mHLA-DR. Outcomes were noted for survival, mortality and secondary infection during the hospital stay. Results: Forty-seven children with median (IQR) age 24 (10, 96) months and a median (IQR) and duration of illness of 3 (3, 5) days, were enrolled consecutively. Pediatric Logistic Organ Dysfunction (PELOD) score >10 was observed in 63.8% children. 18 children succumbed. The median mHLA-DR levels (ABC) at P1 were significantly higher in children who survived as compared with those who expired (7409 vs. 2509, P = 0.004). Similarly, the median mHLA-DR levels (ABC) at P2 were higher in those who survived than the expired group (14728 vs. 2085, P = 0.001). The median delta mHLA-DR levels (ABC) were 4574 and 309 for the survived and expired group, respectively (P = 0.012). mHLA-DR at 72 to 120 hrs (P = 0.004), mHLA-DR at 121 to 168 hrs (P = 0.001) and delta mHLA-DR (P = 0.012) was significantly associated with mortality but not associated with secondary infection. A negative correlation was observed between PELOD score and mHLA-DR at P1 (r = -0.25, P = 0.46), at P2 (r = -0.425, P = 0.018) and delta mHLA-DR (r = -0.27, P = 0.41). The area under curve (95%CI) of mHLA-DR expression (ABC) at P2 for a cutoff of < 6631 was 0.966 (0.907, 1.0) to predict mortality in severe sepsis. Conclusion: mHLA-DR levels were significantly lower in children who succumbed than those who survived at both time points. mHLA-DR levels can be a useful biomarker to diagnose immune-paralysed state.
Abstract 156: Study of Neutrophil Lymphocyte Ratio, Platelet Lymphocyte Ratio, RDW And Hba1c in Subject with Type 2 Diabetes Mellitus and Their Correlation with Diabetic Nephropathy and Retinopathy

NeeleshKumar Dwivedi,Pushpraj Singh,Sanjay Totade

DOI: https://doi.org/10.4103/2230-8210.363661

2022-01-01

Indian Journal of Endocrinology and Metabolism

Abstract:Background: 17% in the world with diabetes is from India. Chronic inflammation plays a central role in the development and progression of diabetes and in the pathogenesis of its complication. NLR should be used as a marker of diabetic control level ln addition to HbA1C ln type 2 diabetic subjects. RDW might be considered as an effective predictive index in the evaluation of diabetic nephropathy or diabetes associated complications. MPV is higher in those who have microvascular complications such as retinopathy or Microalbuminuria. Objective: To study the changes in various haematological parameters in type 2 diabetic mellitus patients. To assess Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, mean platelet volume (MPV), HbA1c cand RDW as a predictive inflammatory marker in type 2 diabetic mellitus. To correlate the haematologicalchanges in type 2 diabetes mellitus patients associated with diabetic nephropathy and retinopathy. Material and Method: It’s a case control study included 200 sample – 100 case (diabetic) and 100 control (non-diabetic). Results: 200 patients included in study 100 cases (diabetic) in which 57.8% (male) and 42.2% (female) has diabetes. Most of the age group between 55-65 yrs of age (38%) has diabetes NLR raised in diabetic group shows significant value (0.001). MPV raised in diabetic group and is significant (0.0001). PLR raise in diabetic group as compared to control group shows significance (0.0001) and HbA1c raised in patient with microvascular complication. RDW significantly raised in case than control group. Conclusion: In this study with non- diabetic group as control, haematological parameter in diabetic patients in outdoor patient department and during hospital stay analysed found that patient with microvascular complications and with raised HbA1C (>7.5%) has significantly raised NLR, PLR, MPV, RDW. Simple complete blood count can be used as an effective tool to monitor glycemic regulation in type 2 DM.
Serum Interleukin-18 Levels Are Raised in Diabetic Ketoacidosis in Chinese Children with Type 1 Diabetes Mellitus.

Guanping Dong,Li Liang,Junfen Fu,Chaochun Zou

2007-01-01

Abstract:Objective: To investigate the role of serum interleukin (IL-18) in children with type I diabetes mellitus (TIDM) and diabetic ketoacidosis (DKA). Design:Case-control study. Subjects: Sixty-one children with TIDM including 28 with DKA and 33 without DKA and 30 age - and sex-matched healthy controls were recruited Methods: Serum IL-18, IL-12, and IFN-gamma levels were measured in all subjects by enzyme linked immunosorbent assay. Results: Serum IL-18 levels were significantly higher in patients with DKA than those inpatients without DKA (759.2 +/- 353.8pg/mL vs. 634.9 +/- 399.7pg/mL, P = 0.001) and healthy controls (310.0 +/- 265.3 pg/mL). The serum IL-12 and IFN-gamma levels were not different between patients and controls (277.5 +/- 207pglniL vs. 351.4 +/- 223.4 pg/mL, P=0.45 and 7.02 +/- 7.53 pg/mL vs. 5.59 +/- 5.34 pg/mL, P=0.21, respectively). Conclusion:Serum IL-18 levels are increased in children with type I diabetes mellitus and could be a predictor of diabetic ketoacidosis.
Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia

Todd A. Florin,Lilliam Ambroggio,Cole Brokamp,Yin Zhang,Mantosh Rattan,Eric Crotty,Michael A. Belsky,Sara Krueger,Thomas N. Epperson,Andrea Kachelmeyer,Richard Ruddy,Samir S. Shah

DOI: https://doi.org/10.1542/peds.2019-3728

2020-06-01

PEDIATRICS

Abstract:BACKGROUND: Host biomarkers predict disease severity in adults with community-acquired pneumonia (CAP). We evaluated the association of the white blood cell (WBC) count, absolute neutrophil count (ANC), C-reactive protein (CRP), and procalcitonin with the development of severe outcomes in children with CAP. METHODS: We performed a prospective cohort study of children 3 months to 18 years of age with CAP in the emergency department. The primary outcome was disease severity: mild (discharged from the hospital), mild-moderate (hospitalized but not moderate-severe or severe), moderate-severe (eg, hospitalized with receipt of intravenous fluids, supplemental oxygen, complicated pneumonia), and severe (eg, intensive care, vasoactive infusions, chest drainage, severe sepsis). Outcomes were examined within the cohort with suspected CAP and in a subset with radiographic CAP. RESULTS: Of 477 children, there were no statistical differences in the median WBC count, ANC, CRP, or procalcitonin across severity categories. No biomarker had adequate discriminatory ability between severe and nonsevere disease (area under the curve [AUC]: 0.53–0.6 for suspected CAP and 0.59–0.64 for radiographic CAP). In analyses adjusted for age, antibiotic use, fever duration, and viral pathogen detection, CRP was associated with moderate-severe disease (odds ratio 1.12; 95% confidence interval, 1.0–1.25). CRP and procalcitonin revealed good discrimination of children with empyema requiring chest drainage (AUC: 0.83) and sepsis with vasoactive infusions (CRP AUC: 0.74; procalcitonin AUC: 0.78), although prevalence of these outcomes was low. CONCLUSIONS: WBC count, ANC, CRP, and procalcitonin are generally not useful to discriminate nonsevere from severe disease in children with CAP, although CRP and procalcitonin may have some utility in predicting the most severe outcomes.

pediatrics
Normal Saline Versus Ringer's Lactate for Intravenous Fluid Therapy in Children with Diabetic Ketoacidosis: A Randomized Controlled Trial

Devanshi Singhal,Shalu Gupta,Virendra Kumar

DOI: https://doi.org/10.1007/s12098-024-05240-9

2024-09-20

Abstract:Objectives: To compare normal saline (NS) and ringer's lactate (RL) as intravenous fluid therapy in children with diabetic ketoacidosis (DKA). Methods: This was a triple blinded randomized controlled trial conducted in the Pediatric Intensive Care Unit (PICU) of a tertiary care hospital in New Delhi from November 2018 to March 2020. The study compared intravenous fluid therapy with ringer's lactate and normal saline in children aged 6 mo to 18 y with DKA as defined by The International Society for Pediatric and Adolescent Diabetes (ISPAD). The primary objective was comparing the time taken to achieve resolution of acidosis (pH ≥ 7.3) in both groups. Secondary objectives included comparing the proportion of patients that develop acute kidney injury; comparing the time taken for normalization of anion gap and blood glucose; time taken to change the type of fluid; total amount of fluid and insulin administered; and total length of PICU and hospital stay. Results: Fifty patients were enrolled, with 25 in each arm and all but one achieved the primary outcome. The median age of the patients was 9 (5, 12) y. The time taken for resolution of acidosis in patients treated with NS was 12 (4, 18) h and with RL was 8 (4, 10) h (p = 0.16). The NS group had a significantly higher incidence of hyperchloremia (p < 0.05) and longer PICU stay (p < 0.05). The metabolic profile and incidence of complications were comparable in both groups. Conclusions: Ringer's lactate can safely be considered for the management of pediatric DKA and may be preferred in patients that are at a risk of complications due to hyperchloremia.
Multicentre, retrospective cohort study protocol to identify racial and ethnic differences in acute kidney injuries in children and adolescents with diabetic ketoacidosis

Bergmann,K. R.,Bjornstad,P.,Abuzzahab,M. J.,Zhong,L.,Collins-Dippel,E.,Nickel,A.,Watson,D.,Kharbanda,A.

DOI: https://doi.org/10.1136/bmjopen-2024-086261

IF: 3.006

2024-06-06

BMJ Open

Abstract:Introduction Approximately 40% of children with diabetic ketoacidosis (DKA) develop acute kidney injury (AKI), which increases the risk of chronic kidney damage. At present, there is limited knowledge of racial or ethnic differences in diabetes-related kidney injury in children with diabetes. Understanding whether such differences exist will provide a foundation for addressing disparities in diabetes care that may continue into adulthood. Further, it is currently unclear which children are at risk to develop worsening or sustained DKA-related AKI. The primary aim is to determine whether race and ethnicity are associated with DKA-related AKI. The secondary aim is to determine factors associated with sustained AKI in children with DKA. Methods and analysis This retrospective, multicentre, cross-sectional study of children with type 1 or type 2 diabetes with DKA will be conducted through the Paediatric Emergency Medicine Collaborative Research Committee. Children aged 2–18 years who were treated in a participating emergency department between 1 January 2020 and 31 December 2023 will be included. Children with non-ketotic hyperglycaemic-hyperosmolar state or who were transferred from an outside facility will be excluded. The relevant predictor is race and ethnicity. The primary outcome is the presence of AKI, defined by Kidney Disease: Improving Global Outcomes criteria. The secondary outcome is 'sustained' AKI, defined as having AKI ≥48 hours, unresolved AKI at last creatinine measurement or need for renal replacement therapy. Statistical inference of the associations between predictors (ie, race and ethnicity) and outcomes (ie, AKI and sustained AKI) will use random effects regression models, accounting for hospital variation and clustering. Ethics and dissemination The Institutional Review Board of Children's Minnesota approved this study. 12 additional sites have obtained institutional review board approval, and all sites will obtain local approval prior to participation. Results will be presented at local or national conferences and for publication in peer-reviewed journals.

medicine, general & internal
Using population data to understand the epidemiology and risk factors for diabetic ketoacidosis in Australian children with type 1 diabetes

Amanda Ampt,Tegan Gemert,Maria E. Craig,Kim C. Donaghue,Samantha B. Lain,Natasha Nassar

DOI: https://doi.org/10.1111/pedi.12891

2019-07-16

Pediatric Diabetes

Abstract:<h3 class="article-section__sub-title section1"> Background</h3><p>Children with type 1 diabetes (T1D) are at risk of diabetic ketoacidosis (DKA) at T1D diagnosis and/or subsequently.</p><h3 class="article-section__sub-title section1"> Objective</h3><p>To determine the incidence and prevalence of T1D by presence of DKA and identify characteristics of subsequent DKA episodes.</p><h3 class="article-section__sub-title section1"> Subjects</h3><p>The study population included all children aged <15 years with T1D during a hospital/day‐stay admission in New South Wales, Australia from 1‐Jan‐2001 to 31‐Dec‐2013. T1D and DKA were identified using ICD‐10‐AM codes.</p><h3 class="article-section__sub-title section1"> Methods</h3><p>Data sources included routinely‐collected longitudinally‐linked population hospitalisation and birth records. Chi‐squared analyses, logistic and multinomial regression were used to determine the association between child characteristics and admissions with and without DKA.</p><h3 class="article-section__sub-title section1"> Results</h3><p>The point prevalence of T1D among 0‐14 year olds on 31‐Dec‐2013 was 144.2 per 100,000. For children aged 0‐12 years, the incidence of T1D was 16.3 per 100,000 child‐years. One‐third had DKA at T1D diagnosis and were more likely to be readmitted with DKA than those without DKA at T1D diagnosis. Children with more than one readmission for DKA were more likely to be female, reside in an inner regional area or an area of socio‐economic disadvantage, and be Australian‐born. Among all hospitalisations of children with T1D, those with DKA were more likely to be aged 10‐14 years, require intensive care, have longer length of stay and admitted outside school days.</p><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Routinely collected administrative health data is a reliable source to monitor incidence and health service use of childhood T1D. Children at risk of repeated DKA, particularly females, adolescents and those from inner regional or socio‐economically disadvantaged areas, should be targeted during education and follow‐up.</p><p>This article is protected by copyright. All rights reserved.</p>

pediatrics,endocrinology & metabolism
Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study

Xiaowan Li,Lanyu Wang,Min Liu,Hongyi Zhou,Hongyang Xu

DOI: https://doi.org/10.3389/fendo.2023.1285509

IF: 6.055

2024-01-05

Frontiers in Endocrinology

Abstract:Aims: This investigation examined the possibility of a relationship between neutrophil-to-lymphocyte ratio (NLR) and diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM) patients. Methods: Adults with T2DM who were included in the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2020 were the subjects of the current cross-sectional investigation. Low estimated glomerular filtration rate (eGFR) (< 60 mL/min/1.73 m 2 ) or albuminuria (urinary albumin-to-creatinine ratio (ACR) ≥ 30 mg/g) in T2DM patients were the diagnostic criteria for DKD. Weighted multivariable logistic regression models and generalized additive models were used to investigate the independent relationships between NLR levels with DKD, albuminuria, and low-eGFR. Additionally, we examined the relationships between DKD, albuminuria, and low-eGFR with other inflammatory markers, such as the aggregate index of systemic inflammation (AISI), systemic immune-inflammation index (SII), system inflammation response index (SIRI), and platelet-to-lymphocyte ratio (PLR) and monocyte-to-lymphocyte ratio (MLR). Their diagnostic capabilities were evaluated and contrasted using receiver operating characteristic (ROC) curves. Results: 44.65% of the 7,153 participants who were recruited for this study were males. DKD, albuminuria, and low-eGFR were prevalent in 31.76%, 23.08%, and 14.55% of cases, respectively. Positive correlations were seen between the NLR with the prevalences of DKD, albuminuria, and low-eGFR. Subgroup analysis and interaction tests revealed that the associations of NLR with DKD, albuminuria, and low-eGFR were not significantly different across populations. In addition, MLR, SII and SIRI showed positive associations with the prevalence of DKD. ROC analysis discovered that when compared to other inflammatory markers (MLR, PLR, SII, SIRI, and AISI), NLR may demonstrate more discriminatory power and accuracy in assessing the risk of DKD, albuminuria, and low-eGFR. Conclusion: Compared to other inflammatory markers (MLR, PLR, SII, SIRI, and AISI), NLR may serve as the more effective potential inflammatory marker for identifying the risk of DKD, albuminuria, and low-eGFR in US T2DM patients. T2DM patients with elevated levels of NLR, MLR, SII, and SIRI should be closely monitored for their potential risk to renal function.

endocrinology & metabolism
Risk factors for adverse outcomes in children with diabetic ketoacidosis

Maha F Yousif,Katie D Dolak,Soumya Adhikari,Perrin C White

DOI: https://doi.org/10.1210/clinem/dgae500

2024-07-20

The Journal of Clinical Endocrinology & Metabolism

Abstract:Abstract Objective Develop a multivariable model to identify children with diabetic ketoacidosis (DKA) and/or hyperglycemic hyperosmolar state (HHS) at increased risk of adverse outcomes, and apply it to analyze adverse outcomes during and after the COVID-19 pandemic. Design Retrospective review of clinical data from 4565 admissions (4284 with DKA alone, 31 [0.7%] only HHS, 250 [5.4%] hyperosmolar DKA) to a large academic children’s hospital from January 2010-June 2023. 2010-2019 data (N=3004) were used as a training dataset, and 2020-2021 (N=903) and 2022-2023 (N=658) data for validation. Death or intensive care unit stays >48 hours comprised a composite “Adverse Outcome” group. Risks for this composite outcome were assessed using generalized estimating equations. Results There were 47 admissions with Adverse Outcomes (1.5%) in 2010-2019, 46 (5.0%) in 2020-2021, and 16 (2.4%) in 2022-2023. Eight patients died (0.18%). Maximum serum glucose, initial pH and diagnosis of type 2 diabetes most strongly predicted Adverse Outcomes. The proportion of patients with type 2 diabetes was highest in 2020-2021. A multivariable model incorporating these factors had excellent discrimination (area under receiver operator characteristic curve [AUC] of 0.948) for the composite outcome in the training dataset, and similar predictive power (AUC 0.960 and 0.873) in the 2020-2021 and 2022-2023 validation datasets, respectively. In the full dataset, AUC for death was 0.984. Conclusions Type 2 diabetes and severity of initial hyperglycemia and acidosis are independent risk factors for Adverse Outcomes, and explain the higher frequency of Adverse Outcomes during the COVID-19 pandemic. Risks decreased in January 2022-June 2023.

endocrinology & metabolism

PATIENTS' CONCEPTIONS OF THERAPISTS.

Plant protoplasts: status and biotechnological perspectives.

MON-107 Diabetic Ketoacidosis at Type 1 Diabetes Diagnosis in Children from a Large Centre (hangzhou, China)

Changes of blood electrolytes and lipids in type 1 diabetes mellitus children with ketoacidosis (DKA)

A 10-Year Review of Childhood Type 1 Diabetes Mellitus and the Clinical Value of Interleukin-10 in Diabetic Ketoacidosis

Changes of blood electrolytes and lipids in type 1 diabetes meilitus children with ketoacidosis(DKA)

Influence of a lymphokine fraction containing eosinophil stimulation promoter (ESP) on oxidative and degranulation responses of murine eosinophils.

Platelet-to-Lymphocyte Ratio: A Novel Prognostic Factor for Prediction of 90-day Outcomes in Critically Ill Patients With Diabetic Ketoacidosis.

1956-LB: Altered Gut Microbiota and Short-Chain Fatty Acids in Children with Diabetic Ketoacidosis at Onset of Type 1 Diabetes

Acquired atopic disease after liver transplantation in children; similarities to and differences from adults: a preliminary study

A HOSPITAL BASED PROSPECTIVE STUDY TO ASSESSED THE CORRELATION BETWEEN GLYCEMIC CONTROL, LIPID PROFILE AND ORAL LEUKOPLAKIA IN DIABETES PATIENTS

Clinical and biochemical profile of 786 sequential episodes of diabetic ketoacidosis in adults with type 1 and type 2 diabetes mellitus

Monocytic Human Leukocyte Antigen-DR Expression Levels to Predict Outcome in Children With Severe Sepsis

Abstract 156: Study of Neutrophil Lymphocyte Ratio, Platelet Lymphocyte Ratio, RDW And Hba1c in Subject with Type 2 Diabetes Mellitus and Their Correlation with Diabetic Nephropathy and Retinopathy

Serum Interleukin-18 Levels Are Raised in Diabetic Ketoacidosis in Chinese Children with Type 1 Diabetes Mellitus.

Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia

Normal Saline Versus Ringer's Lactate for Intravenous Fluid Therapy in Children with Diabetic Ketoacidosis: A Randomized Controlled Trial

Multicentre, retrospective cohort study protocol to identify racial and ethnic differences in acute kidney injuries in children and adolescents with diabetic ketoacidosis

Using population data to understand the epidemiology and risk factors for diabetic ketoacidosis in Australian children with type 1 diabetes

Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study

Risk factors for adverse outcomes in children with diabetic ketoacidosis